Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 31, 2014

View Archived Issues

Exact Sciences gains unanimous FDA panel vote for Cologuard

Washington Roundup: March 26 the effective date for FDA's IIE notification process

Deals Roundup: Hardy Diagnostics becomes an employee-owned company

Agreements/Contracts: CryoLife acquires rights for ProCol from Hancock Labs

HIT Roundup: 3Pound launches Euco platform for patient-clinician engagement

Abbott's Supera given FDA approval for PAD treatment

Product briefs

People in Places

Briefly Noted

MDD's Neurology Extra

International report: Accuray's CyberKnife M6 receives Shonin approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026